MT Newswires
Oppenheimer Adjusts Price Target on BridgeBio Pharma to $81 From $83, Maintains Outperform Rating
📈
AI Sentiment
Highly Positive
8/10
BridgeBio Pharma Inc. News
Latest updates and market news for BBIO
9 news
Feb 20 - Feb 26, 2026
Page 1
MT Newswires
Morgan Stanley Lifts Price Target on BridgeBio Pharma to $98 From $96, Keeps Overweight Rating
📈
AI Sentiment
Highly Positive
8/10
GuruFocus.com
BridgeBio Pharma Inc (BBIO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
📊
AI Sentiment
Positive
7/10
Zacks
BridgeBio Pharma (BBIO) Reports Q4 Loss, Beats Revenue Estimates
📉
AI Sentiment
Negative
3/10
Motley Fool
BridgeBio (BBIO) Q4 2025 Earnings Call Transcript
📈
AI Sentiment
Highly Positive
10/10
MarketBeat
BridgeBio Pharma Q4 Earnings Call Highlights
Associated Press Finance
BridgeBio Pharma: Q4 Earnings Snapshot
Share this news page